DRAA_ECOLX
ID DRAA_ECOLX Reviewed; 160 AA.
AC P24093;
DT 01-MAR-1992, integrated into UniProtKB/Swiss-Prot.
DT 01-MAR-1992, sequence version 1.
DT 25-MAY-2022, entry version 100.
DE RecName: Full=Dr hemagglutinin structural subunit;
DE Flags: Precursor;
GN Name=draA;
OS Escherichia coli.
OC Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC Enterobacteriaceae; Escherichia.
OX NCBI_TaxID=562;
RN [1]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC STRAIN=Serotype O75;
RX PubMed=1670929; DOI=10.1128/iai.59.1.261-268.1991;
RA Swanson T.S., Bilge S.S., Nowicki B., Moseley S.L.;
RT "Molecular structure of the Dr adhesin: nucleotide sequence and mapping of
RT receptor-binding domain by use of fusion constructs.";
RL Infect. Immun. 59:261-268(1991).
RN [2]
RP PROTEIN SEQUENCE OF 22-46.
RC STRAIN=5026, and 950;
RX PubMed=1968432; DOI=10.1128/iai.58.3.695-702.1990;
RA Kist M.L., Salit I.E., Hoffman T.;
RT "Purification and characterization of the Dr hemagglutinins expressed by
RT two uropathogenic Escherichia coli strains.";
RL Infect. Immun. 58:695-702(1990).
CC -!- FUNCTION: Hemagglutinins of uropathogenic E.coli mediate adherence to
CC the upper urinary tract. These adhesins bind to the Dr blood group
CC antigen and also agglutinate human erythrocytes in the presence of D-
CC mannose (mannose-resistant hemagglutination (MRHA)).
CC -!- SUBCELLULAR LOCATION: Fimbrium.
CC -!- SIMILARITY: Belongs to the Dr-adhesin family. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; M62834; AAA23709.1; -; Genomic_DNA.
DR RefSeq; WP_063269203.1; NZ_NJLI01000067.1.
DR PDB; 1USQ; X-ray; 1.90 A; A/B/C/D/E/F=21-160.
DR PDB; 1UT1; X-ray; 1.70 A; A/B/C/D/E/F=21-160.
DR PDB; 2JKJ; X-ray; 2.30 A; A/B/C/D/E/F=23-160.
DR PDB; 2JKL; X-ray; 1.90 A; A/B/C/D/E/F=23-160.
DR PDB; 2JKN; X-ray; 1.90 A; A/B/C/D/E/F=23-160.
DR PDB; 2W5P; X-ray; 1.90 A; A/B/C=23-160.
DR PDBsum; 1USQ; -.
DR PDBsum; 1UT1; -.
DR PDBsum; 2JKJ; -.
DR PDBsum; 2JKL; -.
DR PDBsum; 2JKN; -.
DR PDBsum; 2W5P; -.
DR AlphaFoldDB; P24093; -.
DR BMRB; P24093; -.
DR SMR; P24093; -.
DR DrugBank; DB07492; Bromamphenicol.
DR DrugBank; DB00446; Chloramphenicol.
DR DrugBank; DB07565; Chloramphenicol succinate.
DR DrugBank; DB08621; Thiamphenicol.
DR EvolutionaryTrace; P24093; -.
DR GO; GO:0009289; C:pilus; IEA:UniProtKB-SubCell.
DR Gene3D; 2.60.40.1570; -; 1.
DR InterPro; IPR006713; Adhesin_Dr.
DR InterPro; IPR021020; Adhesin_Dr_signal_peptide.
DR InterPro; IPR008966; Adhesion_dom_sf.
DR InterPro; IPR037028; Dr_adhesin_sf.
DR Pfam; PF04619; Adhesin_Dr; 1.
DR Pfam; PF12393; Dr_adhesin; 1.
DR SUPFAM; SSF49401; SSF49401; 1.
PE 1: Evidence at protein level;
KW 3D-structure; Direct protein sequencing; Fimbrium; Signal.
FT SIGNAL 1..21
FT /evidence="ECO:0000269|PubMed:1968432"
FT CHAIN 22..160
FT /note="Dr hemagglutinin structural subunit"
FT /id="PRO_0000000874"
FT REGION 22..75
FT /note="Receptor-binding"
FT /evidence="ECO:0000255"
FT VARIANT 43
FT /note="R -> Y (in strain: 950 and 5026)"
FT STRAND 22..37
FT /evidence="ECO:0007829|PDB:1UT1"
FT STRAND 39..46
FT /evidence="ECO:0007829|PDB:1UT1"
FT STRAND 50..52
FT /evidence="ECO:0007829|PDB:1UT1"
FT HELIX 53..55
FT /evidence="ECO:0007829|PDB:1UT1"
FT STRAND 61..71
FT /evidence="ECO:0007829|PDB:1UT1"
FT STRAND 75..81
FT /evidence="ECO:0007829|PDB:1UT1"
FT HELIX 83..85
FT /evidence="ECO:0007829|PDB:1UT1"
FT STRAND 90..95
FT /evidence="ECO:0007829|PDB:1UT1"
FT STRAND 101..111
FT /evidence="ECO:0007829|PDB:1UT1"
FT STRAND 114..117
FT /evidence="ECO:0007829|PDB:1UT1"
FT STRAND 120..125
FT /evidence="ECO:0007829|PDB:1UT1"
FT STRAND 130..139
FT /evidence="ECO:0007829|PDB:1UT1"
FT STRAND 146..159
FT /evidence="ECO:0007829|PDB:1UT1"
SQ SEQUENCE 160 AA; 17058 MW; 8F282F8FF1500788 CRC64;
MKKLAIMAAA SMVFAVSSAH AGFTPSGTTG TTKLTVTEEC QVRVGDLTVA KTRGQLTDAA
PIGPVTVQAL GCDARQVALK ADTDNFEQGK FFLISDNNRD KLYVNIRPTD NSAWTTDNGV
FYKNDVGSWG GIIGIYVDGQ QTNTPPGNYT LTLTGGYWAK